Key statistics
On Friday, Pulse Biosciences Inc (6L8:STU) closed at 15.70, 45.37% above the 52 week low of 10.80 set on Nov 21, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 16.10 |
|---|---|
| High | 16.20 |
| Low | 15.60 |
| Bid | 15.80 |
| Offer | 16.00 |
| Previous close | 16.20 |
| Average volume | 457.14 |
|---|---|
| Shares outstanding | 67.99m |
| Free float | 17.88m |
| P/E (TTM) | -- |
| Market cap | 1.27bn USD |
| EPS (TTM) | -1.08 USD |
Data delayed at least 15 minutes, as of Feb 27 2026.
More ▼
Press releases
- Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference
- Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results
- Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium
- Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026
- Pulse Biosciences’ nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium
- Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
- Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium
- Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation
More ▼
